- Lois et règlements
- eservices
-
Media Center
Hotline for Health Services for Displaced Lebanese 1787Hotline for the Patient Admission to Hospitals 01/832700COVID-19 Vaccine Registration Form covax.moph.gov.lbMoPH Hotline 1214
Are you a new member? Sign up now
close
VIMPAT - 150mg - 56
| ATC | B/G | Ingredients | code | Registration Nb | brand_name | Dosage | Presentation | Form | Route | Agent | Laboratory | man_country | Price | Pharmacist Margin | Startum | Responsible Party Name | Responsible Party Country | Exch_date | %SUBSIDY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| N03AX18 | B | Lacosamide - 150mg | 7471 | 185983/13 | VIMPAT | 150mg | 56 | Tablet, film coated | Oral | Sadco | Aesica Pharmaceuticals GmbH | Germany | 11,754,896 L.L | 21.26 | C | UCB Pharma SA | Belgium | 2/5/2024 | 0 |